← FDA DRUG APPROVALS

FDA ANDA · ANDA061876

CERUBIDINE

Sponsor: SANOFI AVENTIS US

APPLICATION
ANDA061876
TYPE
ANDA
ORIGINAL APPROVAL
1980-02-05
LATEST ACTION
1980-02-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CERUBIDINEDiscontinued
DAUNORUBICIN HYDROCHLORIDE EQ 20MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

1980-02-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →